The conversation around kratom vs. 7-oh has intensified in recent years as both substances gain visibility in wellness markets and public health discussions. While often associated with one another, kratom and 7-OH are not the same. Understanding how they differ—chemically, pharmacologically, and in terms of risk—is essential for anyone considering using them.
This article explains the difference between kratom and 7-oh in clear, practical terms, grounded in current scientific data and regulatory perspectives.
What Is Kratom?
Kratom refers to the leaves of the Mitragyna speciosa, a tropical tree native to Southeast Asia.[1] For centuries, people in Thailand, Indonesia, and neighboring regions have used kratom leaves for their stimulating and pain-relieving properties.
The kratom plant contains multiple alkaloids, which are natural compounds that interact with the brain. The most important of these is mitragynine, the main alkaloid responsible for many of kratom’s effects.
Today, kratom is widely sold in the United States as a dietary supplement, often in forms such as:
- Kratom powder, which is made from dried leaves
- Capsules and tablets
- Liquid kratom extracts
- High-potency products that are sold in smoke shops, gas stations, and convenience stores
Despite its “natural” label, kratom is pharmacologically active and behaves more like a drug than a traditional food supplement.
What Is 7-OH?
7-OH refers to 7-hydroxymitragynine, a highly potent compound found in kratom. It is one of the active compounds derived from mitragynine and occurs naturally in the plant in small amounts.[2]
However, modern manufacturing has changed the landscape. Some kratom products are now engineered to contain significantly higher concentrations of 7-OH, creating high-potency products that differ substantially from traditional kratom.
What sets 7-OH apart:
- It is far more potent than mitragynine
- It strongly activates mu opioid receptors
- It produces pronounced opioid like effects
- It may carry significant risks, especially at higher doses
In simple terms, kratom is the plant, while 7-OH is one of its most powerful chemical components.
Kratom vs 7-OH: Key Pharmacological Differences
The most important distinction lies in how these substances interact with the body’s opioid receptors.
Kratom contains a mix of alkaloids that act on several receptor systems, including:
- Mu opioid receptors (pain relief, euphoria)
- Kappa opioid receptors (mood and perception effects)
Mitragynine, the dominant compound, has relatively mild activity compared to classical opioids like morphine.
7-OH, by contrast, is much more direct and intense in its action. Research shows that 7-OH binds strongly to mu opioid receptors, producing effects that resemble classical opioids more closely than kratom itself.[3]
This difference explains why:
- Kratom may feel stimulating at low doses and sedating at higher doses
- 7-OH tends to produce stronger sedative and analgesic effects even at lower amounts
In practical terms, 7-OH behaves less like a plant-based supplement and more like a potent opioid-like substance.
Potency and Dose Considerations
One of the most critical aspects of the kratom vs. 7-oh comparison is potency.
Studies suggest that 7-OH can be many times more potent than mitragynine. While kratom users often consume grams of kratom powder, only small amounts of 7-OH may produce strong effects.
This creates a risk gap:
- Traditional kratom use: lower potency, more gradual effects
- 7-OH concentrated products: rapid onset, significantly higher risk of overdose-like symptoms
At higher doses, both kratom and 7-OH can produce:
- Sedation
- Nausea
- Confusion
- Respiratory depression (rare with kratom alone, but more concerning with high-potency extracts)
Risks and Adverse Effects
Both kratom and 7-OH carry significant risks, particularly when used frequently or in combination with other substances.
Reported Adverse Effects
Data from U.S. poison centers highlight growing concerns. According to the Centers for Disease Control and Prevention (CDC), there were over 2,300 kratom-related exposure calls reported between 2011 and 2017, with many involving serious adverse events such as:[4]
- Agitation and tachycardia
- Seizures
- Confusion
- Coma
More recent surveillance indicates that kratom-related calls continue to rise, often involving co-use with other drugs.
Liver Toxicity and Contamination
Kratom has been associated with liver toxicity in some cases. Additionally, independent testing has found contamination in certain products, including:
- Heavy metals such as lead and nickel
- Microbial contamination
These issues are especially concerning because kratom is often marketed as a natural product, which can lead to an underestimation of its risks.
Dependence and Withdrawal
Both kratom and 7-OH can be habit-forming. Regular kratom use may lead to withdrawal symptoms similar to mild opioid withdrawal, including:[5]
- Anxiety
- Insomnia
- Muscle aches
- Irritability
With higher exposure to 7-OH, these symptoms may be more intense, reflecting its stronger action on opioid receptors.
Addiction and Substance Use Disorder
The relationship between kratom and addiction remains complex.
Some individuals report using kratom to manage opioid withdrawal or reduce reliance on prescription opioids. However, this does not eliminate the potential for substance abuse or substance use disorder.
Clinical observations suggest:
- Kratom can lead to dependency with regular use
- 7-OH may increase addiction risk due to its potency
- Individuals with a history of opioid use disorder are particularly vulnerable
The concern is not only the substance itself but also how it is used—especially in combination with other substances or without medical supervision.
Legal Status and Regulation
The legal status of kratom varies widely.
In the United States, kratom is not currently scheduled under the Controlled Substances Act, but it remains under scrutiny by the U.S. Food and Drug Administration (FDA). The FDA has repeatedly warned consumers about safety concerns and the lack of approved medical uses.
Some states and municipalities have banned kratom outright, while others have adopted the kratom consumer protection act, which aims to regulate product quality and labeling.
Internationally, kratom is banned or restricted in several other countries, including Thailand (historically, though laws have evolved), Australia, and parts of Europe.
As for 7-OH, regulatory attention is increasing, particularly for products that artificially elevate its concentration.
Public Health Perspective
From a public health standpoint, kratom occupies a gray area.
On one hand:
- Some individuals use it as an alternative to opioids
- It may have a role in harm reduction, though evidence is limited
On the other hand:
- Lack of standardization leads to inconsistent dosing
- High-potency products increase risk
- Co-use with other drugs raises the likelihood of serious outcomes
The FDA has stated that kratom has “opioid properties” and may expose users to the risks of addiction, misuse, and dependence.
Treatment and Detox Considerations
For individuals experiencing dependence, treatment approaches are similar to those used for other opioids.
Options may include:
- Gradual tapering under medical supervision
- Symptom management for withdrawal
- In some cases, medications used in opioid use disorder treatment
Severe cases may require medical detox, especially when:
- High doses or kratom extracts are involved
- There is co-use with other substances
- Withdrawal symptoms are intense
A structured detox program can reduce complications and improve outcomes.
Get Connected to Help for Kratom and 7-OH Addiction
The question of kratom or 7-oh is not simply a matter of preference. It is a question of risk, potency, and intent.
Kratom is a complex plant with multiple alkaloids, producing varied effects, while 7-OH is a potent derivative that amplifies opioid-like activity. Both can lead to adverse effects, dependence, and health problems.
For casual users, the distinction may seem subtle. From a clinical and safety perspective, it is substantial.
The rise of high-potency products—especially those enriched with 7-OH—marks a shift away from traditional use toward something closer to pharmaceutical-grade exposure, but without the safeguards.
Anyone considering these substances should weigh the significant risks, stay informed about evolving laws, and seek professional guidance when needed.
If you or a loved one is addicted to 7-oh or kratom, it’s time to seek help. At Archstone Recovery, we provide the resources and treatment you need to recover. Contact us today for more information on how to get started.
Frequently Asked Questions (FAQ)
1. How is 7-OH produced in commercial kratom products?
While 7-OH occurs naturally in the kratom plant, the levels found in raw kratom leaves are very low. In many modern kratom products, especially kratom extracts, manufacturers may chemically convert mitragynine into 7-OH or concentrate it during processing. This results in high-potency products with significantly higher levels than what would be found in traditional dried leaves, which can alter both the effects and the risk profile.
2. Can kratom or 7-OH show up on a drug test?
Standard drug tests typically screen for common drugs like opioids, amphetamines, and benzodiazepines. Kratom and 7-OH are not usually included in routine panels. However, specialized tests can detect kratom’s alkaloids. In some cases, cross-reactivity may occur, leading to false positives, though this is not common. Testing policies may vary depending on the employer or legal setting.
3. Why do some people experience different effects from the same kratom product?
The effects of kratom use can vary widely due to several factors:
- Differences in alkaloid content between batches
- Presence of other substances or contaminants like heavy metals
- Individual body chemistry and tolerance
- Whether the product contains elevated levels of 7-oh
Because kratom is not standardized like approved medications, variability between products sold in smoke shops, gas stations, and online retailers is a significant concern.
4. Is it safe to combine kratom or 7-OH with other medications?
Combining kratom or 7-OH with other drugs or medications can increase the risk of serious adverse effects. This is especially true for substances that also affect the brain or opioid receptors, such as:
- Prescription opioid medications
- Antidepressants or anti-anxiety drugs
- Alcohol or sedatives
These combinations may increase the likelihood of respiratory depression, sedation, or other dangerous interactions. Use alongside any medication should only be considered under medical supervision.
5. Are there quality standards for kratom products in the U.S.?
There is no federal standardization for kratom as a dietary supplement, and the U.S. Food and Drug Administration does not approve kratom for any medical use. However, some states have implemented the Kratom Consumer Protection Act, which sets basic requirements for labeling, age restrictions, and contamination limits. Even in regulated areas, oversight can vary, so product quality is not guaranteed.
6. What should someone do if they experience adverse reactions to kratom or 7-OH?
If someone experiences concerning symptoms—such as severe anxiety, confusion, seizures, or signs of withdrawal—they should seek medical attention promptly. Contacting local poison centers or emergency services is recommended in acute situations. For ongoing issues, including substance use disorder or dependence, professional treatment options such as supervised detox and long-term support can help manage symptoms safely and reduce health risks.
References:
- The National Institute on Drug Abuse (NIDA): Kratom
- ACS Publications: 7-Hydroxymitragynine Is an Active Metabolite of Mitragynine and a Key Mediator of Its Analgesic Effects
- The Food and Drug Administration (FDA): 7-Hydroxymitragynine (7-OH): An Assessment of the Scientific Data and Toxicological Concerns Around an Emerging Opioid Threat
- The Centers for Disease Control and Prevention (CDC): Notes from the Field: Unintentional Drug Overdose Deaths with Kratom Detected — 27 States, July 2016–December 2017
- Research Gate: Kratom Withdrawal: Discussions and Conclusions of a Scientific Expert Forum
